Lou Simpson

Last Update: 11-14-2016

Number of Stocks: 13
Number of New Stocks: 3

Total Value: $2,512 Mil
Q/Q Turnover: 13%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Lou Simpson Watch

  • Lou Simpson Goes 2 for 2 in 3rd Quarter

    Lou Simpson (Trades, Portfolio), manager of SQ Advisors LLC, eliminated his positions in Valeant Pharmaceuticals International Inc. (NYSE:VRX) and U.S. Bancorp (NYSE:USB) during the third quarter. With the proceeds from these two transactions, Simpson invested in Axalta Coating Systems Ltd. (NYSE:AXTA) and Sensata Technologies Holding N. V. (NYSE:ST). These transactions align with the guru’s investing strategy of investing in understandable companies.

    Brief investor introduction


  • A High-Tech Manufacturer With Excellent Growth Prospects

    When AMETEK (NYSE:AME) reported its third-quarter results Tuesday, it continued its give-and-take story of this year: gains from recent acquisitions and losses from exposure to the oil and gas industry.

    AMETEK designs and manufactures electronic instruments, electromechanical devices and other products. It specializes in products that demand high precision or accuracy, and these differentiated products help it generate strong margins.


  • 15 Questions With Matthew Peterson

    Matthew Peterson is a managing partner at Peterson Capital Management. We discuss the investors he admires, hidden assets and fundamental analysis.

    1. How and why did you get started investing? What is your background?


  • Valeant: Heads I Win, Tails I Don't Lose Much

    There are several reasons to dislike Valeant Pharmaceuticals (NYSE:VRX). Lack of management credibility, accounting irregularities and other legal investigations related to a price increase on a couple of drugs have caused its share price to fall from the high of $260 to $28.95. Investors in the company, including me, had a stomach-churning experience.

    It's always disheartening to see the value of the investment fall within a space of few months, or even days in this case. The market has a way of humbling even the best of hedge fund managers: Bill Ackman (Trades, Portfolio), Value Act, Sequoia and Lou Simpson (Trades, Portfolio) all have large stakes in Valeant. A few of them had a cost basis in the mid 100's.


  • Lou Simpson Buys Berkshire, Wells Fargo, US Bancorp

    Lou Simpson (Trades, Portfolio) manages a portfolio composed of 12 stocks with a total value of more than $3 billion. During the fourth quarter, he increased his stakes in the following seven stocks.

    The guru increased his stake in Valeant Pharmaceuticals International Inc. (VPX) by 38.18% with an impact of 2.51% on the portfolio.


  • Is Valeant a Good Buy Now?

    Valeant Pharmaceuticals (NYSE:VRX) has been on a wild ride over the past several years. It was once the stock market darling when its stock price jumped from $40 per share in 2012 to $250 per share in July last year. Then it plunged to only $87 at the time of this writing. Investors have been in doubt about the company’s business model and accounting practices. However, value investors such as Lou Simpson (Trades, Portfolio) and T Rowe Price Associates have been buying its shares. Should we follow them into this stock? Let’s dig deeper.

    In October last year, Citron released its bearish research on the company. Citron focused on the company’s relationship with Philidor and R&O Pharmacy. It pointed out that Philidor and R&O Pharmacy were the same company with the same toll-free number to reach the privacy officer. Citron also compared the company with infamous Enron, the company with hot stock and fraudulent accounting in 2001. Before joining Enron in 1990, Jeff Skilling had no experience running a business, having spent 11 years working for McKinsey. Michael Pearson, Valeant's ex-CEO, also worked for McKinsey for 23 years before joining Valeant. Citron thought that when others discovered Philidor, Valeant said the company had purchased an option to acquire Philidor in late 2014. In the report, Citron lowered their target price to $50 per share.


  • In Vast Difference From Berkshire Style, Lou Simpson Adds to Valeant Position

    Former Geico CIO Lou Simpson (Trades, Portfolio) is well known for having been a trusted manager of the Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) subsidiary, of whom Warren Buffett often sang the praises in his annual shareholder letters. As demonstrated in his fourth-quarter trades, however, Simpson can also have vastly different investment ideas than what can be considered a classic Buffett company.

    One clear example of Simpson’s occasional differences from Buffett and Charlie Munger (Trades, Portfolio)’s style is his current investment in Valeant Pharmaceuticals (NYSE:VRX), whose troubles dominated headlines toward the end of last year. In the fourth quarter, Simpson purchased an additional 745,631 shares in Valeant, upping his stake by 38%. The average price paid for the shares was $112.18, about half the average price he paid during the previous quarter.


  • Lou Simpson Adds to Valeant Stake

    Guru Lou Simpson (Trades, Portfolio) ran the Geico insurance, a subsidiary of Berkshire Hathaway (BRK.A) (BRK.B) for more than three decades with outstanding returns. In his 2004 letters to shareholders, Warren Buffett (Trades, Portfolio) dedicated an entire section to Lou Simpson (Trades, Portfolio) called "Portrait of a Disciplined Investor."



  • Don't Let Mr. Market Separate You From a Great Company

    Over a five-year period, the price of a stock will largely track the fundamentals of the company rather than its quarterly economic reports. We live in a world in which information on virtually anything is no further away than your smartphone.

    With the ability to access information and the media’s reporting on the stock market as though it were a sports event, investors lose track of the long term and focus too much on the short term.


  • Lou Simpsons' High Quality Stocks Include Ametek, Berkshire

    Warren Buffett met Lou Simpson (Trades, Portfolio) in 1996 when he was CEO of Geico's capital operations and Buffett was completing his purchase of Geico. Throughout his time with Berkshire, Simpson and Buffett's stock picks sometimes overlapped due to similarities in their thinking, but both men clearly had independent processes and disagreed with each other sometimes as well.

    The following are the holdings in Simpson's portfolio with the highest GuruFocus business predictability rating.


  • Lou Simpson Increases 7 Stakes in 3rd Quarter

    Warren Buffett met Lou Simpson in 1996 when he was CEO of Geico's capital operations and Buffett was completing his purchase of the insurance company. Buffett kept Simpson on as chief investment officer. At his retirement from Geico in 2010, Simpson managed more than $4 billion worth of stocks.

    During the third quarter, Simpson's investment firm SQ Advisors bought shares of seven companies, and all of them have been additions to existing stakes.


  • Simpson and Greenberg Buy Brookfield Despite Negative Report

    Recently the Probes Reporter wrote a negative report on Brookfield Asset Management (NYSE:BAM) calling it "An Unanalyzable Black Box." In the report it discusses several government investigations, lack of disclosures about the investigations and Brookfield Asset Management's financial engineering.

    This comes about 2½ years after the Southern Investigative Reporting Foundation "SIRF" wrote a negative report discussing Brookfield Asset Management's history, IFRS accounting practices and other issues. SIRF would write another report six months later in November 2013 further questioning Brookfield Asset Management.


  • Buffett-Endorsed Investor Lou Simpson's Top 5 Stock Increases

    Lou Simpson (Trades, Portfolio), an investor with Warren Buffett (Trades, Portfolio) connections, disclosed Monday he boosted stakes in his largest holdings during the third quarter and purchased no new stocks.

    Simpson’s portfolio activity during the quarter resulted in two new top positions in the portfolio – Ametek Inc. (NYSE:AME) and Brookfield Asset Management (NYSE:BAM) – replacing Charles Schwab Corp. (NYSE:SCHW) and Valeant Pharmaceuticals (NYSE:VRX). Other largest increases were to Liberty Global PLC (NASDAQ:LBTYK), Valeant and Berkshire Hathaway (NYSE:BRK.B).


  • My Indirect Experiences With Valeant Pharmaceuticals

    Valeant Pharmaceuticals International Inc. (NYSE:VRX) has been a hot topic recently with high-profile investors and short sellers both involved in one of the most interesting dramas ever. Valeant's shareholder base includes some of the most admired investors including Bill Ackman (Trades, Portfolio), Jeff Ubben (Trades, Portfolio), the Sequoia Fund, Lou Simpson (Trades, Portfolio) and Wallace Weitz. It is really fascinating to watch on the sideline as the events unfold.

    This is not intended to add any personal thoughts on whether or not Valeant’s business is legitimate or not as I don’t know enough about the business to have useful insights. But over the past year, I’ve been exposed to Valeant in a few incidents, which I think may be worthwhile to share with the readers.


  • Lou Simpson Boosts Stake in Charles Schwab

    Warren Buffett (Trades, Portfolio) once dedicated a section of his annual letter to shareholders to Lou Simpson (Trades, Portfolio), who was Buffett’s chief investment officer at Geico for more than a decade. The section about Simpson was titled “Portrait of a Disciplined Investor.” When Simpson retired in 2010, he managed more than $4 billion worth of stocks.

    Simpson’s most significant transaction in the second quarter was his addition of 3,896,783 shares to his existing stake in Charles Schwab Corp. (NYSE:SCHW), a brokerage and banking company based in San Francisco. Simpson paid an average price of $31.58 per share in a deal that had a 4.13% impact on his portfolio.


  • GuruFocus Interview: Jeff Auxier of Auxier Asset Management

    At 11 years old, Jeff Auxier (Trades, Portfolio) began mowing the lawn of Georgia Pacific’s then-CEO Bob Pamplin Sr., who led the company to be one of the top-performing NYSE stocks of the time. After graduating college with his degree in finance and starting his career in 1982, Auxier decided to cold call Warren Buffett (Trades, Portfolio) — and got an answer.

    Whether by luck or simply taking a chance, Auxier was influenced by value investors from an early age, and this is reflected in his firm, Auxier Asset Management. The firm is based far from Wall Street on the opposite coast in Portland, Oregon, where Auxier lives on a 108-acre hazelnut farm.


  • Simpson and Buffett BOTH own this wide moat stock.

    Precision Castparts (NYSE:PCP) was founded in Portland, Oregon circa 1949. The company manufactures structural investment castings, forged components and airfoil castings for aircraft jet engines and power turbines.

    Despite having a website that looks straight out of 1999, doing the brand zero justice, the underlying company is rock solid. It has large customers like General Electric (NYSE:GE), Rolls-Royce (RR.), Airbus (NYSE:AIR) and Boeing (NYSE:BA) that have all bought from the company for decades.


  • Lou Simpson Adds Precision Castparts to Portfolio in First Quarter

    Warren Buffett (Trades, Portfolio) has called Lou Simpson (Trades, Portfolio) “a cinch to be inducted into the investment hall of fame,” and he should know. Simpson was CEO of capital operations for GEICO when Buffett bought the company in 1996, and he remained with the company until 2010.

    Over a quarter of a century, Simpson produced average annual gains of more than 20%.


  • This Buffet-Munger Name Is More Growth Stock than Value Stock

    When pension funds and big money managers want value propositions beyond the stock and bond markets, they call on companies like Brookfield Asset Management Inc. (NYSE:BAM).

    We might call it one of the 800-pound gorillas literally searching the world for under-priced assets, especially in real estate, renewable energy, and infrastructure (among others). Brookfield has more than $200-billion in assets under management, and a big war chest that will allow it to make major acquisitions when it finds properties it likes.


  • Guru Stocks at 52-Week Lows: UPS, HST, KORS, FAST, TIF

    According to GuruFocus' list of 52-week lows, these Guru stocks have reached their 52-week lows.

    United Parcel Service Inc reached the 52-week low of $96.14


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)